Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Local Institution - 007-712-Ph2

Guangzhou, Guangdong 510120, ChinaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Lung cancer

Closed trials

Recruiting
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
NCT04613596· Phase 2/3· Mirati Therapeutics Inc.· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Local Institution - 007-712-Ph2: trial site – Frontlight Research